Helping you reach a healthy life, full of possibility.
When every moment counts, our therapies help healthcare specialists provide life-sustaining treatment to you or your loved one.
From the pharmacy to the bedside, we support you and your healthcare providers with IV medications and infusion technologies designed with safety in mind.
When medical conditions prevent you from adequately feeding yourself, we provide life-saving clinical nutrition options to help you regain or maintain your health.
Chronic kidney disease (CKD) is an ongoing journey. While every journey is unique, Baxter is with you every step of the way, providing options to meet your lifestyle needs.
We partner with surgical teams around the world so they can operate with confidence, precision and speed for a successful outcome to your surgery.
Committed to helping you meet the evolving challenges and opportunities in patient care.
Providing innovative therapies and technologies to help you treat patients with life-threatening illnesses in the ICU.
From the pharmacy to the bedside, we help you maximize safety, streamline processes and build cost efficiency throughout the hospital.
Acute and chronic nutritional care for your patients who are unable to get adequate nutrients orally or enterally.
Pioneering innovation in hemodialysis and peritoneal dialysis to help you achieve better outcomes for your patients.
Delivering innovative surgical products that help you operate with confidence, precision and speed.
Our portfolio of acute, nutritional, renal, hospital and surgical care products helps advance healthcare around the world.
For more than 85-years, we have worked at the intersection of saving and sustaining lives.
Joe Almeida shares his outlook on a range of topics.
Patients’ journeys inspire our work and drive our commitment.
We’re engaging with industry thought leaders to explore how science and innovation advance healthcare.
Enriching the communities where we live and work.
Our more than 85-year heritage gives us distinct perspective on the needs of patients and caregivers. We lead today by putting those insights to work to deliver new, better healthcare solutions and access to care in the communities where we live and work.
Our forward-looking leadership team is a driving force in ensuring we meet the needs of all our stakeholders – every day and everywhere.
We are proud of our strong commitment to maintaining the highest standards of corporate governance.
Nurturing a culture of innovation is critical to delivering on our mission to save and sustain lives. We partner with the healthcare community to continually find more efficient, smarter ways to help solve the world's most pressing healthcare challenges.
We are committed to doing business the right way, ensuring that we champion our employees, our communities, our customers and patients, and our environment in everything we do.
We are committed to attracting, motivating and retaining an inclusive and diverse workforce.
For more than 85 years, we’ve been focused on saving and sustaining lives and elevating patient care.
Our objective is to accelerate growth by expanding Baxter’s impact across the healthcare spectrum supported by the evolution of our new product pipeline.
Information regarding Baxter’s recent announcements, upcoming & past events, and other useful resources for investors.
Baxter's Annual Chairman Letter, Proxy Statement and Form 10-K filings sorted by year.
Financial schedules and Non-GAAP reconciliations by quarter.
All Forms filed with the U.S. Securities and Exchange Commission sorted by year.
Upcoming, featured, and past events and presentations. Also read the latest news on Baxter innovations and initiatives, and follow us on our corporate social media channels.
Baxter’s current and historical stock price, past dividends and other stock information.
Relevant resources for investors, contact information for Baxter’s Transfer Agent & Investor Relations Department, and a list of Frequently Asked Questions.
Find useful information regarding the cost basis associated with Baxter’s various spin-off companies
Find historical Dividend and Stock Split History such as: Record and Payable Date, Amount, and Type
Find contact information for Baxter's Investor Relations Department and Transfer Agent
Find useful information regarding corporate governance at Baxter
Caremark
Allegiance
Edwards LifeSciences
Baxalta
Baxalta Exchange Offer
Baxter registered shareholders now have the option of viewing future annual reports and proxy statements on the Internet. Baxter registered shareholders can sign up to receive these materials via e-mail instead of having paper copies sent through the regular mail, which saves Baxter printing and mailing costs, and is a more environmentally-friendly practice. To register for this service, please go to computershare.com or contact our transfer agent, Computershare, at 888-359-8645. If you are a first-time user, you will need to enroll in Computershare’s Investor Center located on their website.
Please note, if you own your stock through a broker or bank, you will need to contact your broker or bank to process your request for electronic delivery of the annual report and proxy statement.
Baxter dividends are subject to approval by the Board of Directors. Baxter has historically paid quarterly cash dividends on its shares of common stock and currently expects to continue to do the same in the future. For more information on historical dividends paid by Baxter, please visit the All Dividends page.
Yes, Baxter does offer an automatic dividend reinvestment program to all holders of Baxter International Inc. common stock. To set up automatic dividend reinvestment please contact our transfer agent, Computershare. If you own your stock through a broker or bank, you will need to contact your broker or bank to process your request for automatic dividend reinvestment.
With every dividend declaration by the Board, Baxter discloses the record date and payment date in a press release, which is also posted on Baxter’s website. The record date is the day upon which the shareholders of record are entitled to the upcoming dividend payment. However, it is important to be aware of the ex-dividend date, which will impact whether or not you receive the next dividend (see discussion below). The payment date is the day when the dividend checks will actually be mailed to the shareholders of a company or credited to brokerage accounts.
The ex-dividend date is the first date when buying a stock does not entitle the new buyer to the declared dividend, as the transfer of stock ownership cannot be completed before the company initiates the dividend payment. The ex-dividend date is set by the NYSE and is normally one business day before the dividend record date. As a result, if you purchase a stock on the ex-dividend date or after, you will not receive the next dividend payment. Instead, the seller of the stock gets the dividend. If you purchase the stock before the ex-dividend date, you are entitled to receive the dividend.
If you have two or more accounts in the same name, contact Computershare, our transfer agent, and ask to have your accounts consolidated. With respect to two or more shareholders who share the same address, we mail a single Annual Report and proxy statement to the household unless a shareholder notifies Computershare that he/she would like individual copies.
No. You must be a shareholder of record as of the applicable record date in order to receive a dividend payment. In addition, if you purchase stock on the ex-dividend date or after, you will not receive the next dividend payment.
Baxter’s CUSIP for the common stock is 071813109.
Baxter common stock is listed as “BAX” (ticker symbol) on the New York, Chicago and Swiss Exchanges. The New York Stock Exchange is the only market on which Baxter’s common stock is traded.
Information regarding historical prices of Baxter stock can be found on the Stock Information page under the Historical Lookup section.
Baxter is headquartered in Deerfield, Illinois, just north of Chicago.
Baxter International Inc. One Baxter Parkway Deerfield, Illinois 60015 Telephone: (224) 948-2000
Baxter shareholders of record may direct questions concerning stock accounts, transfers, lost or missing certificates, dividend checks or other service matters to Baxter’s transfer agent, Computershare.
By Regular Mail Shareholder correspondence should be mailed to: Computershare P.O. Box 505000 Louisville, KY 40233-5000 United States of America
By Overnight Delivery Computershare 462 South 4th Street, Suite 1600 Louisville, KY 40202 United States of America
Telephone: (888) 359-8645 Hearing Impaired Telephone: (800) 952-9245
Shareholder website: www.computershare.com/investor Shareholder online inquiries: https://www-us.computershare.com/investor/Contact
Currently, Baxter’s only security trading on the NYSE is our common stock; symbol BAX. There has been no change to the nature or status of that security. The listing symbol BAX_P represented the Equity Units that were issued by Baxter in December of 2002. The Equity Units were delisted from the NYSE on February 16, 2006 as a result of the settlement as of such date of the purchase contract component of the Equity Units. The purchase contract component entitled holders of Equity Units to receive shares of Baxter common stock on a fixed date for an agreed upon price. For each Equity Unit you would have received 1.4011 shares of Baxter common stock on February 16, 2006.
Baxter shareholders of record may direct questions concerning stock accounts, transfers, lost or missing certificates, dividend checks or other service matters to Baxter’s transfer agent, Computershare (formerly EquiServe).
Computershare.com
Analysts, portfolio managers, and current and prospective shareholders seeking additional investor information can contact Baxter International’s IR Department.
Retail shareholder inquires may directed to Baxter Investor Relations at:
Global_CORP_Investor_Relations@baxter.com
Shareholder correspondence should be mailed to: Computershare P.O. Box 43078 Providence, RI 02940-3078
Baxter International Inc. Investor Relations Department One Baxter Parkway, Mailstop 3-2E Deerfield, IL 60015
Representatives are available weekdays 9:00a.m. - 5:00p.m. (EST) and an automated voice response system is available 24 hours a day: (888) 359-8645
Clare Trachtman Vice President, Investor Relations Telephone: (224) 948-3020 Fax: (224) 948-4498
Shareholder correspondence should be mailed to: Computershare P.O. BOX 30170 College Station, TX 77842-3170